Steven R. Grossman appointed deputy director of Massey

Steve GrossmanSteven R. Grossman, M.D., Ph.D., has been appointed the deputy director of Virginia Commonwealth University Massey Cancer Center. This new position of deputy director was added to support the continuation of Massey’s upward trajectory and considerable growth over the last few years.

“Since Dr. Grossman joined Massey in July 2011, he has shown that he is an excellent fit for this position, and his extensive skills, experience and expertise have provided added value,” said Gordon D. Ginder, M.D., director of VCU Massey Cancer Center.

As the chair of one of the most important and largest academic units contributing to the cancer center and one of the largest divisions in the Department of Internal Medicine at VCU School of Medicine – the Division of Hematology, Oncology and Palliative Care, Grossman has played a key role in implementing the strategic vision and future of educational programs, research and clinical service lines related to oncology.

He has significantly contributed to the growth of Massey’s cadre of experts by helping to recruit several senior-level scientists and physician-researchers as well as junior investigators, clinical educators and clinicians. Additionally, his support of a collaborative research environment has been important in moving promising ideas from the laboratory bench to the patient bedside, helping Massey to open several exciting early phase clinical trials.

“In his short time at Massey, Grossman has made extraordinary contributions that are helping to propel the cancer center’s mission forward,” Ginder stated further.

As deputy director, Grossman will lead the planning and development of disease-specific scientific research groups; oversee clinical oncology interactions; and develop strategic initiatives in new multidisciplinary research areas. All of these activities are of great importance to the cancer center and will help position Massey for success during the next National Cancer Institute competitive review in 2016, where the center hopes to achieve Comprehensive status, the highest level of NCI designation.

At VCU, Grossman serves in many other important capacities: as the Dianne Nunnally Hoppes Endowed Chair in Cancer Research and member of the Cancer Molecular Genetics and Developmental Therapeutics research programs at Massey; medical director of the Oncology Service Line at the VCU Medical Center; and professor of internal medicine, director of the American Board of Internal Medicine research track and active participant on the M.D./Ph.D. Steering Committee at the VCU School of Medicine.

A researcher and physician, Grossman is a nationally recognized expert in tumor biology and gastrointestinal cancers. He currently holds a National Institutes of Health grant that supports his research examining the role of tumor suppressor proteins in cancer with the goal of developing a new way of treating pancreatic cancer. He was also awarded three grants that are given to support the work of researchers advancing the understanding of basic cancer biology and the development of new methods for its prevention and treatment: the Kimmel Scholar Award from the Sidney Kimmel Foundation for Cancer Research, the Howard Temin Pathway to Independence Award in Cancer Research from the National Cancer Institute and a Research Scholar Award from the American Cancer Society.

Prior to joining Massey, Grossman was an associate professor in the Departments of Cancer Biology and Medicine at the University of Massachusetts Medical School in Worcester. He was also medical director of the Simonds-Sinon Regional Cancer Center and co-director of the Center for Gastrointestinal Oncology at the University of Massachusetts Memorial Medical Center.

New Massey Research Pavilion fosters collaboration among cancer researchers

NewSOMBuilding2A new hub for cancer research known as the Massey Research Pavilion opened in April 2013 in the VCU School of Medicine’s McGlothlin Medical Education Center, a new 12-story, 200,000-square-foot, state-of-the-art building.

The Massey Research Pavilion—located on floors 11 and 12—provides 27,000-square-feet of dedicated space for VCU Massey Cancer Center’s clinical trials research, cancer prevention and control research and Division of Hematology, Oncology and Palliative Care chair, Steven Grossman, M.D., Ph.D., and his administrators. Each floor is appointed with a suite of research offices and conference rooms.

A significant portion of Massey’s clinical research enterprise is housed in the Pavilion. Along with the associate director for clinical research, Charles Geyer, Jr., M.D., F.A.C.P., and the medical director for clinical trials (currently under recruitment), Massey’s medical oncology and hematology early phase clinical investigators are located there. In addition, the Pavilion is home to many of Massey’s clinical research nurses and associates as well as clinical research regulatory staff.

The clinical research team members collaborate with other clinical investigators as well as laboratory researchers from the cancer center’s various scientific programs to develop and oversee clinical trials that reflect both the strengths of Massey’s science and the cancer burden of its patients to ultimately advance cancer treatments.

“By housing the many arms of our clinical research staff in the same building, the Pavilion allows Massey’s faculty to foster robust, collaborative research endeavors that will continue our success as Virginia’s largest provider of cancer clinical trials,” said Gordon D. Ginder, M.D., director of VCU Massey Cancer Center.

Also housed in the Pavilion are the staff members supporting Massey’s Clinical Research Affiliation Network, which extends the cancer center’s promising clinical trials to its statewide clinical research affiliated-community oncology practices and hospitals. Leading the affiliation network is Khalid Matin, M.D., F.A.C.P., Massey’s newly appointed medical director of community oncology and clinical research affiliations.

Space is also available in the Pavilion for planned recruitments in cancer prevention and control research. Cancer prevention and control researchers at Massey study the behavioral, policy, organizational and environmental factors that affect cancer risk, diagnosis, treatment and survival. This research includes community- and patient-based initiatives aimed at educating, raising public awareness and informing decisions that are critical to prevent and control cancer.

Additionally, in the basement of the McGlothlin Medical Education Center is room reserved for shared resource equipment to support multiple Massey research projects.

The Pavilion was made possible by generous donors. To date, more than $4 million in philanthropic funds has been raised to support it. Recently, the Mary Morton Parsons Foundation committed a $1 million grant that challenges Massey to raise $2 million in matching funds by May 2014. Another recent gift was committed by C.T. Hill, a longtime member of the Massey Community Advisory Board and co-chair of the Research for Life Campaign, and his wife, Moria. The Hills’ $250,000 gift has been recognized with the naming of a conference room in their honor.

“Thanks to our generous donors, the Massey Research Pavilion will allow our staff to continue pushing forward Massey’s mission to alleviate the suffering and death caused by cancer,” said Ginder. “We are incredibly fortunate to have a community of donors that understands the long-term payoff for investing in this kind of resource.”